Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerPolicy UpdatesCardiologyAmbetter Nevada ILR/ICM Coverage Prior Auth | Open…
    Ask Trek AI about this page
    CurrentAmbetter NevadaPolicy CP.MP.243

    Implantable Loop Recorder (ILR/ICM) Coverage Criteria

    Customize your policy alerts

    Sign up for Ambetter Nevada Policy CP.MP.243 alerts

    Get alerted when Policy CP.MP.243 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical necessity criteria and coding implications for implantable loop recorders (also called insertable/implantable cardiac monitors) used to detect cardiac arrhythmias for Ambetter Nevada members and providers requesting coverage.

    Policy Summary
    PayerAmbetter Nevada
    PolicyImplantable Loop Recorder (ILR/ICM) Coverage Criteria
    Policy CodePolicy CP.MP.243
    Change TypeNo material changes
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization for ILR insertion or removal and document that 30-day external ambulatory monitoring was inconclusive or contraindicated when required by the criteria.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    2–4 yrs
    Device longevity range
    ≥1Guideline refs
    33285/33286Key CPT codes
    multipleSupportive studies

    Medical Necessity and Coverage Criteria

    Initial Medical Necessity Indications

    Covered when ANY of the following are met:

    Section I: A. Suspected silent atrial fibrillation (AF) in the setting of cryptogenic stroke, when 30-day external ambulatory monitoring is inconclusive or contraindicated;see individual nodes

    Each lettered indication is sufficient on its own if conditions met

    Section I: B. Suspected or known ventricular arrhythmia when 30-day external ambulatory monitoring is inconclusive or contraindicated;see individual nodes

    Each lettered indication is sufficient on its own if conditions met

    Section I: C. History of structural or infiltrative heart disease (e.g., valvular aortic stenosis, hypertrophic cardiomyopathy, cardiac sarcoidosis, congenital heart disease) and BOTH 1) high risk for arrhythmias (e.g., family history, symptoms, anatomy of structural heart disease) and 2) 30-day external ambulatory monitoring (e.g., external loop recorder) is inconclusive or contraindicated;see individual nodes

    Each lettered indication is sufficient on its own if conditions met

    Section I: D. Recurrent, unexplained syncope or presyncope and BOTH 1) cardiac arrhythmia is suspected and external ambulatory monitoring (e.g., 30-day external loop recorder) is inconclusive or contraindicated and 2) symptoms are infrequent (e.g., less than once per month).see individual nodes

    Each lettered indication is sufficient on its own if conditions met

    Secondary-review Indications

    Covered when ALL of the following are met and secondary medical director review is completed:

    Section II: A. Presenting condition is either 1) single, abrupt episode of unexplained syncope without prodrome resulting in injury/trauma OR 2) significant, recurrent and unexplained palpitations;all must be met

    Requires mandatory secondary medical director review

    Section II: B. Serious cardiac arrhythmia is suspected;all must be met

    Requires mandatory secondary medical director review

    Section II: C. 30-day external ambulatory monitoring (e.g., external loop recorder) is inconclusive or contraindicated;all must be met

    Replacement Devices

    Replacement may be considered medically necessary when ALL of the following are met:

    Section III: Existing monitor is no longer functioning and is outside its warranty (e.g., device is nearing the end of its battery life) AND the patient meets the applicable clinical criteria (Sections I or II).all must be met

    Replacement requests evaluated under same clinical criteria

    Services or codes not meeting the medical necessity criteria in Sections I–III are not supported by this clinical policy. CPT and HCPCS codes listed in the policy are provided for informational purposes only and inclusion or exclusion of any code does not guarantee coverage; providers must reference current coding guides and submit claims consistent with the member’s benefits and billing rules.

    Coverage and payment determinations are governed by the member’s specific benefit documents. This clinical policy is a guide to medical necessity and does not constitute a contract or guarantee of payment; coverage is subject to all terms, conditions, exclusions, and limitations of the evidence of coverage or contract and to applicable state and federal requirements (including state Medicaid provisions, which take precedence when in conflict).

    Use of an implantable loop recorder (ILR/ICM) is not supported when 30-day external ambulatory monitoring has not been attempted or is not documented as inconclusive or contraindicated. Per policy, ILR placement is considered when external ambulatory monitoring (for example, up to a 30-day external loop recorder) is unsuccessful or cannot be used; requests that do not document prior external monitoring or a contraindication/inconclusive result are at risk for denial.

    Procedure, Monitoring, and Billing Codes

    Referenced CPT/Monitoring CodesCPT
    33285Insertion, subcutaneous cardiac rhythm monitor, including programming.
    33286Removal, subcutaneous cardiac rhythm monitor.
    93285Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; subcutaneous cardiac rhythm monitor system.
    93291Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; subcutaneous cardiac rhythm monitor system, including heart rhythm derived data analysis.
    93298Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional.
    Referenced HCPCS/G-codesHCPCS
    C1764Event recorder, cardiac (implantable).
    E0616Implantable cardiac event recorder with memory, activator, and programmer.
    G2066Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results.
    inv-09: Symptom frequency
    Symptom frequency thresholdInfrequent events (e.g., less than once per month) favor use of an implantable loop recorder (ILR) when external ambulatory monitoring is inconclusive or contraindicated.
    Guiding principleFrequency of symptoms should dictate the type of recording; longer-term monitoring is required for more infrequent events.
    Clinical applicationFor recurrent, unexplained syncope/presyncope, ILR is appropriate when symptoms are infrequent (eg, < once per month) and external ambulatory monitoring (eg, 30-day) is inconclusive/contraindicated.

    Provider Requirements, Authorization, and Documentation

    Prior Authorization

    Provider Requirements, Authorization, and Documentation

    Prior authorization is required for ILR/ICM insertion and removal. Requests must include documentation that supports the indication (for example, cryptogenic stroke with inconclusive 30-day external monitoring, suspected ventricular arrhythmia, history of structural/infiltrative heart disease with high arrhythmia risk, or recurrent unexplained syncope with infrequent symptoms) and demonstrate that 30-day external ambulatory monitoring was inconclusive or contraindicated when applicable. Providers should recommend and document a trial of longer-term external ambulatory monitoring (e.g., up to 30 days or external loop recorder) prior to ILR when clinically appropriate. Requests that do not meet the medical necessity criteria described in Sections I–III risk denial. Coverage determinations are subject to all terms, conditions, exclusions and limitations of the member's benefit plan, and claims/payment are governed by the plan contract. Providers must verify the clinical policy effective date and comply with any applicable legal or regulatory requirements, including provider notification timelines.

    • Prior authorization required for insertion and removal of ILR/ICM
    • Include supporting documentation: prior external monitoring results, contraindications to external monitoring, symptoms frequency, clinical rationale
    • Document trial of longer-term external ambulatory monitoring (e.g., up to 30 days) when appropriate
    • Requests not meeting Sections I–III medical necessity criteria may be denied
    • Coverage is subject to member benefit terms, exclusions, limitations, and contract provisions

    Device Background and Clinical Context

    An implantable loop recorder (also called an insertable or implantable cardiac monitor) is a subcutaneous cardiac rhythm monitoring device implanted typically in the left pectoral region that automatically and/or patient-activated records cardiac events for prolonged surveillance. Many ILR/ICM systems are MRI-conditional, and device battery longevity varies by manufacturer but is generally in the range of approximately 2–4 years depending on device and usage.

    Key Definitions

    inv-19: ILR/ICM definition
    Device typeSubcutaneous cardiac rhythm monitoring device (also called insertable or implantable cardiac monitor).
    Typical implantation siteLeft pectoral region (subcutaneous implantation).
    Recording modesAutomatically records events per programmed criteria and can be patient-activated to store symptomatic episodes.
    MRI status and longevityDevices are MRI-conditional; battery longevity typically ranges from approximately 2 to 4 years depending on manufacturer and model.
    inv-20: Inconclusive 30-day external ambulatory monitoring
    DefinitionExternal ambulatory ECG monitoring (eg, up to 30 days external loop recorder) that has failed to document a causative arrhythmia for the patient's symptoms or is contraindicated.
    Policy Summary
    PayerAmbetter Nevada
    PolicyImplantable Loop Recorder (ILR/ICM) Coverage Criteria
    Policy CodePolicy CP.MP.243
    Change TypeNo material changes
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization for ILR insertion or removal and document that 30-day external ambulatory monitoring was inconclusive or contraindicated when required by the criteria.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaProcedure, Monitoring, and Billing CodesProvider Requirements, Authorization, and DocumentationDevice Background and Clinical ContextKey Definitions

    Requires mandatory secondary medical director review

    Section II: D. Symptoms are infrequent (e.g., less than once per month).all must be met

    Requires mandatory secondary medical director review

  1. Verify policy effective date and follow applicable legal/regulatory requirements
  2. When considered inconclusive/insufficientWhen prolonged noninvasive monitoring (including intermittent external loop recording up to ~30 days) does not correlate symptoms with arrhythmia or fails to establish a diagnosis.
    Policy implicationAn ILR is considered when 30-day external ambulatory monitoring is inconclusive or contraindicated for indications such as suspected silent AF after cryptogenic stroke, suspected ventricular arrhythmia, high-risk structural heart disease, or unexplained infrequent syncope/presyncope.
    inv-21: Implantable loop recorder
    Clinical definition in literature/guidelinesAn implantable loop recorder (ILR) is a subcutaneously implanted device for prolonged electrocardiographic monitoring to detect intermittent arrhythmias; referenced in guideline and trial literature.
    Role in trials/guidelinesILRs increase diagnostic yield for unexplained syncope and detection of silent atrial fibrillation after cryptogenic stroke and are discussed in guideline and review publications (eg, AHA/ASA and ESC AF guidelines, and clinical reviews).
    Examples of referenced sourcesAHA/ASA stroke prevention guideline (Kleindorfer et al.) and 2020 ESC AF guideline (Hindricks et al.), plus device reviews and clinical practice summaries.